CODEINE O-DEMETHYLATION CO-SEGREGATES WITH POLYMORPHIC DEBRISOQUINE HYDROXYLATION

被引：124

作者：

YUE, QY

SVENSSON, JO

ALM, C

SJOQVIST, F

SAWE, J

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03556.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：639 / 645

页数：7

共 31 条

[1] MORPHINE-6-GLUCURONIDE - ANALGESIC EFFECTS AND RECEPTOR-BINDING PROFILE IN RATS [J].

ABBOTT, FV ;

PALMOUR, RM .

LIFE SCIENCES, 1988, 43 (21) :1685-1695

[2]

ADLER TK, 1955, J PHARMACOL EXP THER, V114, P251

[3] HUMAN CYTOCHROMES-P-450 [J].

BOOBIS, AR ;

DAVIES, DS .

XENOBIOTICA, 1984, 14 (1-2) :151-185

[4]

LADAME C, 1948, Praxis, V37, P723

[5]

CHEN ZR, 1988, LANCET, V2, P914

[6] BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].

DAYER, P ;

DESMEULES, J ;

LEEMANN, T ;

STRIBERNI, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416

[7] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[8] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[9] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[10] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

← 1 2 3 4 →